openPR Logo
Press release

Pharmacogenomics Market 2023-2028 Global Key Manufacturers' Analysis Review

01-11-2024 12:30 PM CET | Health & Medicine

Press release from: The insight partners

Pharmacogenomics Market 2023-2028 Global Key Manufacturers'

The Pharmacogenomics Market report outlines the evolution of Pharmacogenomics Market by type, applications and identifies and assesses the best performing vendors in the market till 2028. Pharmacogenomics Market reports present the revenue opportunities in the Pharmacogenomics Industry through 2023-2028, highlighting the market size and growth by technology, geography, vertical and End users.

Download Sample PDF at https://www.theinsightpartners.com/sample/TIPRE00007564?utm_source=OpenPR&utm_medium=10791

Key Players Analysis:

Hoffmann-la Roche Ltd
Abbott
Oxford Nanopore Technologies
Thermo Fisher Scientific Inc.
Illumina, Inc.
QIAGEN
Agilent Technologies, Inc.
Myriad Genetics, Inc.
Admera Health
Dynamic DNA Laboratories

The report covers key developments in the Pharmacogenomics Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Pharmacogenomics Market are anticipated to have lucrative growth opportunities in the future with the rising demand for Pharmacogenomics Market in the global market. Below mentioned is the list of few companies engaged in the Pharmacogenomics Market.

Research report has been compiled by studying the market in-depth along with drivers, opportunities, restraints & other strategies as well as new-developments that can help a reader to understand the exact situation of the market along with the factors that can limit or hamper the market growth and the report also has been updated with Impacts & effects of Coronavirus pandemic and how it has influenced consumer behaviour & the growth of the market as well as industries.

Get a Full Report Copy @ https://www.theinsightpartners.com/buy/TIPRE00007564/?utm_source=OpenPR&utm_medium=10791

MARKET SEGMENTATION

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Pharmacogenomics Market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Pharmacogenomics Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

Contact US

Contact Person : Ankit Mathur

Phone : +1-646-491-9876

E-mail : sales@theinsightpartners.com

About US

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Pharmacogenomics, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Food and Beverages, Consumers and Goods, Chemicals and Materials.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pharmacogenomics Market 2023-2028 Global Key Manufacturers' Analysis Review here

News-ID: 3349500 • Views:

More Releases from The insight partners

Future of Clean Energy - Complete Guide (PDF)
Future of Clean Energy - Complete Guide (PDF)
With the mounting population and industrialization, the demand for energy is also rising at the global level. This has boosted the need for alternative energy sources, as traditional energy resources such as fossil fuels are directing to environmental pollution. Clean alternative options such as solar and wind curb immense carbon emissions and their negative impact on the environment and help balance the energy supply and demand. Thus, the rise in
Mechanical Thrombectomy Devices Market Size, Demand, Share, Analysis with Focus on Opportunities, Development Strategy, Future Plans, Competitive Landscape and Trends by Forecast to 2031
Mechanical Thrombectomy Devices Market Size, Demand, Share, Analysis with Focus …
An off-the-shelf report on Mechanical Thrombectomy Devices Market which has been compiled after an in-depth analysis of the market trends prevailing across five geographies (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). Various segments of the market such as type/components/ application/industry verticals/ end-users are analyzed with robust research methodology which includes three step process starting with extensive secondary research to gather data from company profiles, global/regional associations, trade
Containment Piping System Market Size, Demand, Analytical Overview, Comprehensive Analysis, Segmentation, Competitive Landscape and Industry Poised for Rapid Growth in Future 2031
Containment Piping System Market Size, Demand, Analytical Overview, Comprehensiv …
Containment Piping System Market study by "The Insight Partners" provides details about the market dynamics affecting the market, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favorable competitive landscape and trends prevailing over the years. This Report encloses comprehensive analysis on the market and are assessed through volume and value data validated on three approaches including top companies' revenues. It concludes with precise and
Nutraceuticals - An Ultimate PDF Guide
Nutraceuticals - An Ultimate PDF Guide
Consumers in developed and some developing countries are highly attracted to functional products, mainly on account of the added health and wellness benefits. Nutraceuticals are associated with various medicinal and health benefits, such as to improve the function of the immune system, boost gut health, and others. Rising healthcare costs, coupled with the increasing geriatric population across the world, propels the adoption of various nutraceuticals such as dietary supplements, functional

All 5 Releases


More Releases for Pharmacogenomics

Pharmacogenomics - Top Companies Regional and Data Analysis
Pharmacogenomics is a branch of science, which studies the role of gene over the activity of a drugs and hence helps the refreshers in predicting the response of novel as well as previously available therapies. Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00007564/?utm_source=OpenPR&utm_medium=10129 Major Companies operating in the Pharmacogenomics Market are: • F. Hoffmann-la Roche Ltd • Abbott • Oxford Nanopore Technologies • Thermo Fisher Scientific Inc. • Illumina, Inc. • QIAGEN • Agilent Technologies, Inc. • Myriad Genetics, Inc. • Admera Health Contact Us: If you have any queries about
Pharmacogenomics Market worth $5.8 billion by 2028
North America region is witnessing increasing investments and research activities in the field of drug discovery and development. The need for advanced therapies due to rising rate of cancer has contributed to growth of the pharmacogenomics market. Pharmacogenomics Market [https://www.marketsandmarkets.com/Market-Reports/pharmacogenomics-market-142682251.html?utm_source=ABnewswire&utm_campaign=Paid&utm_content=Referral] in terms of revenue was estimated to be worth $3.5 billion in 2023 and is poised to reach $5.8 billion by 2028, growing at a CAGR of 10.6% from 2023 to
Genetic Medicine: Unveiling the Power of Pharmacogenomics
Based on technology, the pharmacogenomics market is segmented into PCR, sequencing, microarray, gel electrophoresis, mass spectrometry, and others. The market for the PCR segment is subsegmented into real time PCR, standard PCR, and digital PCR. The PCR segment dominated the pharmacogenomics market in 2021 and is expected to register the highest CAGR during the forecast period. Download Sample PDF Details at: https://www.theinsightpartners.com/sample/TIPRE00007564?utm_source=OpenPR&utm_medium=10776 The pharmacogenomics market is segmented on the basis of
Complete PDF Guide On Pharmacogenomics [PDF]
According to our latest study on "Pharmacogenoics Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Technology, Application, and End User," the market is projected to reach US$ 14,107.80 million by 2028 from US$ 7,087.81 million in 2021; it is expected to grow at a CAGR of 10.3% from 2021 to 2028. The report highlights the key factors driving the market growth and prominent players with their
Global Pharmacogenomics Market Size & Trends
According to a new market research report published by Global Market Estimates, the global pharmacogenomics market is projected to grow at a CAGR of 9.6% from 2023 to 2028. The growth of the global pharmacogenomics market is driven by advancements in genomics and DNA sequencing technologies, the rising demand for personalized medicine, regulatory support from agencies like the FDA, cost-effectiveness through reduced adverse reactions, and a growing aging population with complex
Global Pharmacogenomics Services Market Insights | 2022-2032
The Pharmacogenomics Services Market refers to the services provided by companies and laboratories that offer personalized medicine based on a patient's genetic makeup. Pharmacogenomics is the study of how an individual's genes affect their response to certain drugs, and the pharmacogenomics services market focuses on utilizing this knowledge to optimize drug therapy. These services typically involve genetic testing to identify specific genetic variations that may impact a patient's response to certain